TY  - JOUR
AU  - Wang, Li
AU  - Gong, Yixuan
AU  - Chippada-Venkata, Uma
AU  - Heck, Matthias Michael
AU  - Retz, Margitta
AU  - Nawroth, Roman
AU  - Galsky, Matthew
AU  - Tsao, Che-Kai
AU  - Schadt, Eric
AU  - de Bono, Johann
AU  - Zhu, Jun
AU  - Oh, William K
PY  - 2015
DO  - 10.1186/s12916-015-0442-0
UR  - http://hdl.handle.net/20.500.12105/10315
AB  - Background: Castration-resistant prostate cancer (CRPC) is associated with wide variations in survival. Recent studies of whole blood mRNA expression-based biomarkers strongly predicted survival but the genes used in these biomarker models were...
LA  - eng
PB  - BioMed Central (BMC)
KW  - 1ST-LINE CHEMOTHERAPY
KW  - SURVIVAL
KW  - MEN
KW  - SIGNATURES
KW  - BIOMARKER
KW  - SELECTION
KW  - NETWORK
KW  - Gene Expression Regulation, Neoplastic
KW  - Aged
KW  - Biomarkers, Tumor
KW  - Gene Expression
KW  - Gene Expression Profiling
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Prostatic Neoplasms, Castration-Resistant
KW  - RNA, Messenger
KW  - TO-LYMPHOCYTE RATIO
TI  - A robust blood gene expression-based prognostic model for castration-resistant prostate cancer.
TY  - journal article
ER  -